Kerry acquires C-LEcta and Enmex to fast track food and pharma biotechnologies
date:Feb 16, 2022
enges and new healthier, more sustainable foods and medicines are being created, Dr. Albert McQuaid, chief science and technology officer of Kerry tells.

Based in Leipzig, Germany, c-LEcta is a biotechnology innovation company specializing in precision fermentation, optimized bioprocessing and biotransformation of targeted enzymes and ingredients. The company specializes in disruptive new sciences for the pharmaceutical market with a pipeline of functional bioactives across food, beverage and o
2/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/23 22:49